Merck, Durham and vaccine

Merck opens $1 billion vaccine manufacturing plant, expanding Durham site
Merck has opened a $1 billion, 225,000-square-foot facility at its Durham campus dedicated to vaccine manufacturing, the drug giant announced Tuesday.
Merck opens $1 billion addition in north Durham to boost production of popular vaccine
The drugmaker Merck announced it has opened a $1 billion vaccine manufacturing facility in north Durham, a 225,000-square-foot addition to the company’s existing campus off Old Oxford Road.
New $1 billion plant opens in Durham for vaccine manufacturing
Merck said the facility, which had a ribbon cutting Tuesday, is a 225,000-square-foot state-of-the-art plant, officials said.
Drugmaker Merck opens state-of-the-art $1B facility in Durham
Dave Portnoy, the brash owner of Barstool Sports and President Trump supporter, said he was approached a job in the Trump administration — but that he didn’t want to give up running his sports, gambling and pop-culture media company. Portnoy, who goes by @stoolpresidente on X, posted a video Tuesday on the platform claiming he …
Merck opens $1B vaccine production facility (updated)
According to the company, the new, 225,000-square-foot expansion is a "crucial component" of a more than $12 billion infusion toward U.S. capital investments it's made since 2018.
Drugmaker Merck opens state-of-art $1B facility to manufacture HPV Gardasil, other vaccines
DURHAM, N.C. (WTVD) -- Drugmaker Merck announced Tuesday the opening of a new $1 billion vaccine manufacturing facility in North Durham. The plant will manufacture the HPV vaccines Gardasil and Gardasil 9, while the site as a whole continues to produce vaccines against measles, mumps, rubella, and chickenpox, among other illnesses.
Merck opens $1B Gardasil manufacturing facility in North Carolina
At its sprawling complex in Durham, N.C., Merck has opened a new $1 billion, 225,000-square-foot manufacturing plant slated to produce bulk substance for its megablockbuster HPV vaccine Gardasil.
Merck (NYSE:MRK) Unveils US$1 Billion Durham Facility For Advanced Vaccine Manufacturing Expansion
Merck (NYSE:MRK) announced the opening of a new $1 billion vaccine manufacturing facility in Durham, North Carolina, a major development aligning with the company's broader $12 billion U.S. investment initiative.
Merck Injects $1 Billion To Expand Vaccine Production In US
Merck unveils a $1 billion vaccine manufacturing facility in Durham, North Carolina, expanding its U.S. production and research investments.
Merck Opens Vaccine Manufacturing Facility in North Carolina
Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, as the drugmaker seeks to boost its U.S. manufacturing in the face of President Donald Trump's tariff threats. Drugmakers have been exploring the possibility of government-granted exemptions for domestically manufactured medicines since Trump has threatened to impose 25% tariff on pharmaceutical imports.
Fierce Pharma2d
Merck defeats claims it should have added safety warnings to Gardasil's label, knocking out 200-plus lawsuits
In a decision signed Monday, North Carolina federal judge Kenneth Bell granted Merck’s motion to dismiss the claims of ...
The Business Journals3d
Merck completes $1B North Carolina expansion — more growth on the way
Merck (NYSE: MRK) has opened a new 225,000-square-foot vaccine manufacturing facility in Durham. The pharmaceutical company, headquartered in New Jersey, is also in the process of developing ...